Express Scripts has many years of formulary development expertise and an extensive clinical pharmacy department. Express Scripts develops formularies through a process involving the work of the following committees:
- Therapeutic Assessment Committee
- National Pharmacy & Therapeutics (P&T) Committee
- Value Assessment Committee
For more information about how the National Formulary is developed, see the White Paper: Formulary Development at Express Scripts (PDF file).
About the National Pharmacy and Therapeutics (P&T) Committee
The Express Scripts National P&T Committee consists of 15 non-employee physician members and one pharmacist member from active community and academic-based practices and represents a broad range of medical specialties. Although members receive reimbursement for travel costs and a stipend, their involvement on the P&T Committee reflects their desire to foster better patient care on a national level. The P&T meeting summaries are listed below.
- July 11, 2015 (PDF file)
- May 14, 2015 (PDF file)
- March 14, 2015 (PDF file)
- January 29, 2015 (PDF file)
- December 19, 2014 (PDF file)
- November 8, 2014 (PDF file)
- September 11, 2014 (PDF file)
Our National Formulary
Our National Formulary includes approximately 500 brand-name products and every generic product. Because we are independent (that is, not owned by a pharmaceutical manufacturer), these medications are selected based on clinical quality and cost-effectiveness.
PDF files require Adobe Acrobat Reader.